Multiple Sclerosis and Chronic Cerebrospinal Venous Insufficiency: The Neuroimaging Perspective

References

1. 1.↵
   1. Zamboni P,
   2. Galeotti R,
   3. Menegatti E,
   4. et al

   . Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 2009;80:392–99

   Abstract/FREE Full Text
2. 2.↵
   1. Zamboni P,
   2. Menegatti E,
   3. Galeotti R,
   4. et al

   . The value of cerebral Doppler venous haemodynamics in the assessment of multiple sclerosis. J Neurol Sci 2009;282:21–27. Epub 2009 Jan 13

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Zamboni P,
   2. Menegatti E,
   3. Weinstock-Guttman B,
   4. et al

   . The severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis is related to altered cerebrospinal fluid dynamics. Funct Neurol 2009;24:1333–38
4. 4.↵
   1. Zamboni P,
   2. Menegatti E,
   3. Weinstock-Guttman B,
   4. et al

   . CSF dynamics and brain volume in multiple sclerosis are associated with extracranial venous flow anomalies: a pilot study. Int Angiol 2010;29:140–48

   PubMed
5. 5.↵
   1. Zamboni P,
   2. Galeotti R,
   3. Menegatti E,
   4. et al

   . A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency. J Vasc Surg 2009;50:1348–58.e1–3

   CrossRefPubMedWeb of Science
6. 6.↵
   Experimental multiple sclerosis vascular shunting procedure halted at Stanford. Ann Neurol 2010;67:A13–15

   PubMedWeb of Science
7. 7.↵
   1. Khan O,
   2. Filippi M,
   3. Freedman MS,
   4. et al

   . Chronic cerebrospinal venous insufficiency and multiple sclerosis. Ann Neurol 2010;67:286–90

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Cortes Nino Mdel P,
   2. Tampieri D,
   3. Melançon D

   . Endovascular venous procedures for multiple sclerosis? Mult Scler 2010;16:771–72

   FREE Full Text
9. 9.↵
   First Blinded Study of Venous Insufficiency Prevalence in MS Shows Promising Results. February 10, 2010.Available at: http://www.buffalo.edu/news/10937. Accessed October 26, 2010.
10. 10.↵
    1. Doepp F,
    2. Paul F,
    3. Valdueza JM,
    4. et al

    . No cerebrocervical venous congestion in patients with multiple sclerosis. Ann Neurol 2010;68:173–83

    PubMedWeb of Science
11. 11.↵
    1. Sundstrom P,
    2. Wahlin A,
    3. Ambarki K,
    4. et al

    . Venous and cerebrospinal fluid flow in multiple sclerosis: a case-control study. Ann Neurol 2010;68:255–59

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Singh AV,
    2. Zamboni P

    . Anomalous venous blood flow and iron deposition in multiple sclerosis. J Cereb Blood Flow Metab 2009;29:1867–78

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Brass SD,
    2. Chen NK,
    3. Mulkern RV,
    4. et al

    . Magnetic resonance imaging of iron deposition in neurological disorders. Top Magn Reson Imaging 2006;17:31–40

    CrossRefPubMed
14. 14.↵
    1. Craelius W,
    2. Migdal MW,
    3. Luessenhop CP,
    4. et al

    . Iron deposits surrounding multiple sclerosis plaques. Arch Pathol Lab Med 1982;106:397–99

    PubMedWeb of Science
15. 15.↵
    1. Lassmann H,
    2. Bruck W,
    3. Lucchinetti CF

    . The immunopathology of multiple sclerosis: an overview. Brain Pathol 2007;17:210–18

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Stankiewicz J,
    2. Panter SS,
    3. Neema M,
    4. et al

    . Iron in chronic brain disorders: imaging and neurotherapeutic implications. Neurotherapeutics 2007;4:371–86

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Bakshi R,
    2. Benedict RH,
    3. Bermel RA,
    4. et al

    . T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. Arch Neurol 2002;59:62–68

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Neema M,
    2. Stankiewicz J,
    3. Arora A,
    4. et al

    . T1- and T2-based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosis. J Neuroimaging 2007;17(suppl 1):16S–21S

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Ge Y,
    2. Jensen JH,
    3. Lu H,
    4. et al

    . Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging. AJNR Am J Neuroradiol 2007;28:1639–44

    Abstract/FREE Full Text
20. 20.↵
    1. Hammond KE,
    2. Metcalf M,
    3. Carvajal L,
    4. et al

    . Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron. Ann Neurol 2008;64:707–13

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Khalil M,
    2. Enzinger C,
    3. Langkammer C,
    4. et al

    . Quantitative assessment of brain iron by R(2)* relaxometry in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis. Mult Scler 2009;15:1048–54

    Abstract/FREE Full Text
22. 22.↵
    1. Haacke EM,
    2. Garbern J,
    3. Miao Y,
    4. et al

    . Iron stores and cerebral veins in MS studied by susceptibility weighted imaging. Int Angiol 2010;29:149–57

    PubMedWeb of Science
23. 23.↵
    1. Zivadinov R,
    2. Schirda C,
    3. Dwyer MG,
    4. et al

    . Chronic cerebrospinal venous insufficiency and iron deposition on susceptibility-weighted imaging in patients with multiple sclerosis: a pilot case-control study. Int Angiol 2010;29:158–75

    PubMedWeb of Science
24. 24.↵
    1. Ge Y,
    2. Zohrabian VM,
    3. Osa EO,
    4. et al

    . Diminished visibility of cerebral venous vasculature in multiple sclerosis by susceptibility-weighted imaging at 3.0 Tesla. J Magn Reson Imaging 2009;29:1190–94

    CrossRefPubMed
25. 25.↵
    1. Brooks DJ,
    2. Leenders KL,
    3. Head G,
    4. et al

    . Studies on regional cerebral oxygen utilisation and cognitive function in multiple sclerosis. J Neurol Neurosurg Psychiatry 1984;47:1182–91

    Abstract/FREE Full Text
26. 26.↵
    1. Bakshi R,
    2. Miletich RS,
    3. Kinkel PR,
    4. et al

    . High-resolution fluorodeoxyglucose positron emission tomography shows both global and regional cerebral hypometabolism in multiple sclerosis. J Neuroimaging 1998;8:228–34

    CrossRefPubMedWeb of Science
27. 27.↵
    1. Dawson KT

    . The histology of multiple sclerosis. Trans R Soc Edinburgh 1916;50:517–740

    CrossRef
28. 28.↵
    1. Fog T

    . The topography of plaques in multiple sclerosis with special reference to cerebral plaques. Acta Neurol Scand Suppl 1965;15:1–161

    PubMed
29. 29.↵
    1. Tan IL,
    2. van Schijndel RA,
    3. Pouwels PJ,
    4. et al

    . MR venography of multiple sclerosis. AJNR Am J Neuroradiol 2000;21:1039–42

    Abstract/FREE Full Text
30. 30.↵
    1. Mainero C,
    2. Benner T,
    3. Radding A,
    4. et al

    . In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI. Neurology 2009;73:941–48. Epub 2009 Jul 29

    Abstract/FREE Full Text
31. 31.↵
    1. Tallantyre EC,
    2. Brookes MJ,
    3. Dixon JE,
    4. et al

    . Demonstrating the perivascular distribution of MS lesions in vivo with 7-Tesla MRI. Neurology 2008;70:2076–78

    FREE Full Text
32. 32.↵
    1. Tallantyre EC,
    2. Morgan PS,
    3. Dixon JE,
    4. et al

    . A comparison of 3T and 7T in the detection of small parenchymal veins within MS lesions. Invest Radiol 2009;44:491–94

    CrossRefPubMed
33. 33.↵
    1. Kangarlu A,
    2. Bourekas EC,
    3. Ray-Chaudhury A,
    4. et al

    . Cerebral cortical lesions in multiple sclerosis detected by MR imaging at 8 Tesla. AJNR Am J Neuroradiol 2007;28:262–66

    Abstract/FREE Full Text
34. 34.↵
    1. Kollia K,
    2. Maderwald S,
    3. Putzki N,
    4. et al

    . First clinical study on ultra-high-field MR imaging in patients with multiple sclerosis: comparison of 1.5T and 7T. AJNR Am J Neuroradiol 2009;30:699–702

    Abstract/FREE Full Text
35. 35.↵
    1. Gilbertson JR,
    2. Miller GM,
    3. Goldman MS,
    4. et al

    . Spinal dural arteriovenous fistulas: MR and myelographic findings. AJNR Am J Neuroradiol 1995;16:2049–57

    Abstract
36. 36.↵
    1. Love S,
    2. Louis DN,
    3. Ellison DW

    1. Ferrer I,
    2. Kaste M,
    3. Kalimo H

    . Vascular diseases. In: Love S, Louis DN, Ellison DW eds. Greenfield's Neuropathology. Vol 1. London, UK: Hodder Arnold; 2008;121–240
37. 37.↵
    1. Law M,
    2. Saindane AM,
    3. Ge Y,
    4. et al

    . Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter. Radiology 2004;231:645–52

    CrossRefPubMedWeb of Science
38. 38.↵
    1. Inglese M,
    2. Park SJ,
    3. Johnson G,
    4. et al

    . Deep gray matter perfusion in multiple sclerosis: dynamic susceptibility contrast perfusion magnetic resonance imaging at 3 T. Arch Neurol 2007;64:196–202

    CrossRefPubMedWeb of Science
39. 39.↵
    1. Adhya S,
    2. Johnson G,
    3. Herbert J,
    4. et al

    . Pattern of hemodynamic impairment in multiple sclerosis: dynamic susceptibility contrast perfusion MR imaging at 3.0 T. Neuroimage 2006;33:1029–35

    CrossRefPubMedWeb of Science
40. 40.↵
    1. Wakefield AJ,
    2. More LJ,
    3. Difford J,
    4. et al

    . Immunohistochemical study of vascular injury in acute multiple sclerosis. J Clin Pathol 1994;47:129–33

    Abstract/FREE Full Text
41. 41.↵
    1. Saindane AM,
    2. Law M,
    3. Ge Y,
    4. et al

    . Correlation of diffusion tensor and dynamic perfusion MR imaging metrics in normal-appearing corpus callosum: support for primary hypoperfusion in multiple sclerosis. AJNR Am J Neuroradiol 2007;28:767–72

    Abstract/FREE Full Text
42. 42.↵
    1. Rosso C,
    2. Remy P,
    3. Creange A,
    4. et al

    . Diffusion-weighted MR imaging characteristics of an acute strokelike form of multiple sclerosis. AJNR Am J Neuroradiol 2006;27:1006–08

    Abstract/FREE Full Text
43. 43.↵
    1. Rovira A,
    2. Pericot I,
    3. Alonso J,
    4. et al

    . Serial diffusion-weighted MR imaging and proton MR spectroscopy of acute large demyelinating brain lesions: case report. AJNR Am J Neuroradiol 2002;23:989–94

    Abstract/FREE Full Text
44. 44.↵
    1. Lassmann H

    . Hypoxia-like tissue injury as a component of multiple sclerosis lesions. J Neurol Sci 2003;206:187–91

    CrossRefPubMedWeb of Science
45. 45.↵
    1. Wuerfel J,
    2. Bellmann-Strobl J,
    3. Brunecker P,
    4. et al

    . Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study. Brain 2004;127:111–19

    Abstract/FREE Full Text
46. 46.↵
    1. De Keyser J,
    2. Steen C,
    3. Mostert JP,
    4. et al

    . Hypoperfusion of the cerebral white matter in multiple sclerosis: possible mechanisms and pathophysiological significance. J Cereb Blood Flow Metab 2008;28:1645–51

    CrossRefPubMed
47. 47.↵
    1. Kalman B,
    2. Leist TP

    . A mitochondrial component of neurodegeneration in multiple sclerosis. Neuromolecular Med 2003;3:147–58

    CrossRefPubMedWeb of Science
48. 48.↵
    1. Frischer JM,
    2. Bramow S,
    3. Dal-Bianco A,
    4. et al

    . The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 2009;132:1175–89

    Abstract/FREE Full Text
49. 49.↵
    1. Lassmann H

    . Multiple sclerosis: is there neurodegeneration independent from inflammation? J Neurol Sci 2007;259:3–6

    CrossRefPubMedWeb of Science